TABLE OF CONTENTS
Volume 4, Issue 1 (2004)
Editorial
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base FREE
T E Klein and R B Altman
Pharmacogenomics J 4: 1; doi:10.1038/sj.tpj.6500230
In This Issue
Top of pageNews and Commentary
Re. KC Wilhelmsen, M Schuckit et al (2003): The search for genes related to a low-level response to alcohol determined by alcohol challenges FREE
M Soyka
Pharmacogenomics J 4: 3-4; doi:10.1038/sj.tpj.6500228
Perspective
Promoting comparative molecular studies in environmental health research: an overview of the comparative toxicogenomics database (CTD) FREE
C J Mattingly, G T Colby, M C Rosenstein, J N Forrest Jr and J L Boyer
Pharmacogenomics J 4: 5-8; doi:10.1038/sj.tpj.6500225
Review
Protecting communities in pharmacogenetic and pharmacogenomic research FREE
C Weijer and P B Miller
Pharmacogenomics J 4: 9-16; advance online publication, December 2, 2003; doi:10.1038/sj.tpj.6500219
Original Articles
Multilocus effects of the renin–angiotensin–aldosterone system genes on blood pressure response to a thiazide diuretic FREE
L Frazier, S T Turner, G L Schwartz, A B Chapman and E Boerwinkle
Pharmacogenomics J 4: 17-23; doi:10.1038/sj.tpj.6500215
Evaluation of the carcinogenic effects of furazolidone and its metabolites in two fish species FREE
A Auro, H Sumano, L Ocampo and A Barragán
Pharmacogenomics J 4: 24-28; advance online publication, December 2, 2003; doi:10.1038/sj.tpj.6500216
Association between a G-protein 
3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders FREE
H-J Lee, J-H Cha, B-J Ham, C-S Han, Y-K Kim, S-H Lee, S-H Ryu, R-H Kang, M-J Choi and M-S Lee
Pharmacogenomics J 4: 29-33; advance online publication, December 2, 2003; doi:10.1038/sj.tpj.6500217
CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers FREE
T Fukuda, S Onishi, S Fukuen, Y Ikenaga, M Ohno, K Hoshino, K Matsumoto, A Maihara, K Momiyama, T Ito, Y Fujio and J Azuma
Pharmacogenomics J 4: 34-39; advance online publication, December 2, 2003; doi:10.1038/sj.tpj.6500218
Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors FREE
M Wadelius, K Sörlin, O Wallerman, J Karlsson, Q-Y Yue, P K E Magnusson, C Wadelius and H Melhus
Pharmacogenomics J 4: 40-48; advance online publication, December 16, 2003; doi:10.1038/sj.tpj.6500220
A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia FREE
T M Danoff, D A Campbell, L C McCarthy, K F Lewis, M H Repasch, A M Saunders, N K Spurr, I J Purvis, A D Roses and C-F Xu
Pharmacogenomics J 4: 49-53; advance online publication, December 2, 2003; doi:10.1038/sj.tpj.6500221
Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes FREE
R R Freimuth, M Wiepert, C G Chute, E D Wieben and R M Weinshilboum
Pharmacogenomics J 4: 54-65; advance online publication, December 16, 2003; doi:10.1038/sj.tpj.6500223
Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia FREE
M Krajinovic, É Lemieux-Blanchard, S Chiasson, M Primeau, I Costea and A Moghrabi
Pharmacogenomics J 4: 66-72; advance online publication, December 2, 2003; doi:10.1038/sj.tpj.6500224
